                                                                     
                                                                     
                                                                     
                                             
                         SEQUENCE LISTING

<110>  Roche Diagnostics GmbH
       F. Hoffmann-La Roche AG
       Roche Molecular Systems, Inc.
       
 
<120>  MULTIPLEXED NUCLEIC ACID TARGET IDENTIFICATION

<130>  31896-WO-HS

<150>  US 61/918,896
<151>  2013-12-20

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Forward primer

<400>  1
cctccctcca ggaagcctac gtga                                              24


<210>  2
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse primer


<220>
<221>  modified_base
<222>  (21)..(21)
<223>  t-butyl benzyl-dC

<400>  2
cagtcgaagg gcatgagctg ca                                                22


<210>  3
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  5`-Flap probe


<220>
<221>  misc_feature
<222>  (9)..(10)
<223>  2 x HEG linker

<220>
<221>  misc_feature
<222>  (30)..(30)
<223>  3` phosphate

<400>  3
tttttttttt gcacggtgga ggtgaggcag                                        30


